AimVion A/S
AimVion A/S is a privately held research and development company focused on peptide based drugs for inflammatory and autoimmune diseases.
AimVion A/S operates in biotechnology, health care, pharmaceutical based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2015.
The company sits in the biotechnology, health care, pharmaceutical segment, where it competes on its core product or service.
Its base of operations is European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
Directory data places it at the Seed stage.
The company reports a headcount in the c_00011_00050 range.
| Sector | Biotechnology, Health Care, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2015 |
| Employees | c_00011_00050 |
| Stage | seed |
Website: aimvion.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account